These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 25783475)

  • 1. Virus uncoating is required for apoptosis induction in cultured mammalian cells infected with African horse sickness virus.
    Vermaak E; Theron J
    J Gen Virol; 2015 Jul; 96(Pt 7):1811-20. PubMed ID: 25783475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural Protein VP2 of African Horse Sickness Virus Is Not Essential for Virus Replication In Vitro.
    van Gennip RGP; van de Water SGP; Potgieter CA; van Rijn PA
    J Virol; 2017 Feb; 91(4):. PubMed ID: 27903804
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An African horse sickness virus serotype 4 recombinant canarypox virus vaccine elicits specific cell-mediated immune responses in horses.
    El Garch H; Crafford JE; Amouyal P; Durand PY; Edlund Toulemonde C; Lemaitre L; Cozette V; Guthrie A; Minke JM
    Vet Immunol Immunopathol; 2012 Sep; 149(1-2):76-85. PubMed ID: 22763149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. African horse sickness virus induces apoptosis in cultured mammalian cells.
    Stassen L; Huismans H; Theron J
    Virus Res; 2012 Jan; 163(1):385-9. PubMed ID: 21983259
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis versus survival of African horse sickness virus serotype 4-infected horse peripheral blood mononuclear cells.
    Faber E; Tshilwane SI; Van Kleef M; Pretorius A
    Virus Res; 2022 Jan; 307():198609. PubMed ID: 34688785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and characterization of the two outer capsid proteins of African horsesickness virus: the role of VP2 in virus neutralization.
    Martinez-Torrecuadrada JL; Iwata H; Venteo A; Casal I; Roy P
    Virology; 1994 Jul; 202(1):348-59. PubMed ID: 8009847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bluetongue virus outer capsid proteins are sufficient to trigger apoptosis in mammalian cells.
    Mortola E; Noad R; Roy P
    J Virol; 2004 Mar; 78(6):2875-83. PubMed ID: 14990706
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective immunization of horses with a recombinant canarypox virus vectored vaccine co-expressing genes encoding the outer capsid proteins of African horse sickness virus.
    Guthrie AJ; Quan M; Lourens CW; Audonnet JC; Minke JM; Yao J; He L; Nordgren R; Gardner IA; Maclachlan NJ
    Vaccine; 2009 Jul; 27(33):4434-8. PubMed ID: 19490959
    [TBL] [Abstract][Full Text] [Related]  

  • 9. African horse sickness virus serotype 4 antigens, VP1-1, VP2-2, VP4, VP7 and NS3, induce cytotoxic T cell responses in vitro.
    Faber FE; van Kleef M; Tshilwane SI; Pretorius A
    Virus Res; 2016 Jul; 220():12-20. PubMed ID: 27063332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A correlation between capsid protein VP2 and the plaque morphology of African horse sickness virus in cell culture.
    Schade-Weskott ML; van Schalkwyk A; Koekemoer JJO
    Virus Genes; 2018 Aug; 54(4):527-535. PubMed ID: 29730763
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recombinant baculovirus-synthesized African horsesickness virus (AHSV) outer-capsid protein VP2 provides protection against virulent AHSV challenge.
    Roy P; Bishop DH; Howard S; Aitchison H; Erasmus B
    J Gen Virol; 1996 Sep; 77 ( Pt 9)():2053-7. PubMed ID: 8811002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. African horse sickness virus infects BSR cells through macropinocytosis.
    Vermaak E; Conradie AM; Maree FF; Theron J
    Virology; 2016 Oct; 497():217-232. PubMed ID: 27497184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative ultrastructural characterization of African horse sickness virus-infected mammalian and insect cells reveals a novel potential virus release mechanism from insect cells.
    Venter E; van der Merwe CF; Buys AV; Huismans H; van Staden V
    J Gen Virol; 2014 Mar; 95(Pt 3):642-651. PubMed ID: 24347494
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Purification and properties of virus particles, infectious subviral particles, cores and VP7 crystals of African horsesickness virus serotype 9.
    Burroughs JN; O'Hara RS; Smale CJ; Hamblin C; Walton A; Armstrong R; Mertens PP
    J Gen Virol; 1994 Aug; 75 ( Pt 8)():1849-57. PubMed ID: 8046387
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Membrane permeabilization of the African horse sickness virus VP5 protein is mediated by two N-terminal amphipathic α-helices.
    Stassen L; Huismans H; Theron J
    Arch Virol; 2011 Apr; 156(4):711-5. PubMed ID: 21193936
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine ephemeral fever virus-induced apoptosis requires virus gene expression and activation of Fas and mitochondrial signaling pathway.
    Lin CH; Shih WL; Lin FL; Hsieh YC; Kuo YR; Liao MH; Liu HJ
    Apoptosis; 2009 Jul; 14(7):864-77. PubMed ID: 19521777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors that affect the intracellular localization and trafficking of African horse sickness virus core protein, VP7.
    Bekker S; Huismans H; van Staden V
    Virology; 2014 May; 456-457():279-91. PubMed ID: 24889247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Apoptosis induced in an early step of African swine fever virus entry into vero cells does not require virus replication.
    Carrascosa AL; Bustos MJ; Nogal ML; González de Buitrago G; Revilla Y
    Virology; 2002 Mar; 294(2):372-82. PubMed ID: 12009879
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of T cell and linear B cell epitopes on African horse sickness virus serotype 4 proteins VP1-1, VP2, VP4, VP7 and NS3.
    Faber E; van Schalkwyk A; Ivy Tshilwane S; Van Kleef M; Pretorius A
    Vaccine; 2024 Jan; 42(2):136-145. PubMed ID: 38097459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. African horsesickness virus VP7 sub-unit vaccine protects mice against a lethal, heterologous serotype challenge.
    Wade-Evans AM; Pullen L; Hamblin C; O'Hara R; Burroughs JN; Mertens PP
    J Gen Virol; 1997 Jul; 78 ( Pt 7)():1611-6. PubMed ID: 9225037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.